BACKGROUND AND PURPOSE: Some patients treated with intravenous (IV) tissue-type plasminogen activator (tPA) have negative diffusion-weighted imaging (DWI) on follow-up imaging. Without a visible infarct, there may be uncertainty as to whether the patient was having a stroke that was averted by tPA or whether the symptoms had not been cerebrovascular in origin. We evaluated patients presenting with suspected acute stroke with a positive DWI lesion before IV tPA to determine the probability of finding a negative DWI up to 48 hours after treatment. METHODS: We included patients from the Lesion Evolution in Stroke and Ischemia On Neuroimaging (LESION) project who had acute MRI screening with a positive DWI lesion before IV tPA treatment and had follow-up MRI up to 48 hours later. Experienced readers interpreted all acute and follow-up MRIs looking for ischemic lesions on DWI. RESULTS: There were 231 patients who met study inclusion criteria, of which 225 patients (97.4%) had a persistent positive DWI corresponding to the acute stroke lesion on all follow-up imaging. Four patients (1.7%) had transient DWI lesion reversal with positive DWI on subsequent follow-up imaging. There were only 2 cases (0.9%) of complete DWI lesion reversal on all follow-up imaging. CONCLUSIONS: Averted infarction after IV tPA is rare, occurring in 0.9% of patients with pretreatment positive DWI evidence of acute ischemia. For IV tPA-treated patients who have a negative DWI on follow-up imaging, a cause other than acute stroke should be explored.
BACKGROUND AND PURPOSE: Some patients treated with intravenous (IV) tissue-type plasminogen activator (tPA) have negative diffusion-weighted imaging (DWI) on follow-up imaging. Without a visible infarct, there may be uncertainty as to whether the patient was having a stroke that was averted by tPA or whether the symptoms had not been cerebrovascular in origin. We evaluated patients presenting with suspected acute stroke with a positive DWI lesion before IV tPA to determine the probability of finding a negative DWI up to 48 hours after treatment. METHODS: We included patients from the Lesion Evolution in Stroke and Ischemia On Neuroimaging (LESION) project who had acute MRI screening with a positive DWI lesion before IV tPA treatment and had follow-up MRI up to 48 hours later. Experienced readers interpreted all acute and follow-up MRIs looking for ischemic lesions on DWI. RESULTS: There were 231 patients who met study inclusion criteria, of which 225 patients (97.4%) had a persistent positive DWI corresponding to the acute stroke lesion on all follow-up imaging. Four patients (1.7%) had transient DWI lesion reversal with positive DWI on subsequent follow-up imaging. There were only 2 cases (0.9%) of complete DWI lesion reversal on all follow-up imaging. CONCLUSIONS:Averted infarction after IV tPA is rare, occurring in 0.9% of patients with pretreatment positive DWI evidence of acute ischemia. For IV tPA-treated patients who have a negative DWI on follow-up imaging, a cause other than acute stroke should be explored.
Authors: O Y Chernyshev; S Martin-Schild; K C Albright; A Barreto; V Misra; I Acosta; J C Grotta; S I Savitz Journal: Neurology Date: 2010-03-24 Impact factor: 9.910
Authors: Julio A Chalela; Chelsea S Kidwell; Lauren M Nentwich; Marie Luby; John A Butman; Andrew M Demchuk; Michael D Hill; Nicholas Patronas; Lawrence Latour; Steven Warach Journal: Lancet Date: 2007-01-27 Impact factor: 79.321
Authors: Christiane K Kuhl; Jochen Textor; Jürgen Gieseke; Marcus von Falkenhausen; Sunhild Gernert; Horst Urbach; Hans H Schild Journal: Radiology Date: 2004-12-15 Impact factor: 11.105
Authors: Chelsea S Kidwell; Jeffrey L Saver; Sidney Starkman; Gary Duckwiler; Reza Jahan; Paul Vespa; J Pablo Villablanca; David S Liebeskind; Y Pierre Gobin; Fernando Vinuela; Jeffry R Alger Journal: Ann Neurol Date: 2002-12 Impact factor: 10.422
Authors: Shreyansh Shah; Marie Luby; Karen Poole; Teresa Morella; Elizabeth Keller; Richard T Benson; John K Lynch; Zurab Nadareishvili; Amie W Hsia Journal: Neurology Date: 2015-05-13 Impact factor: 9.910
Authors: Nandakumar Nagaraja; Steven Warach; Amie W Hsia; Harold P Adams; Sungyoung Auh; Lawrence L Latour; José G Merino Journal: JAMA Neurol Date: 2014-12 Impact factor: 18.302
Authors: Alejandro M Brunser; Gabriel Cavada; Paula Muñoz Venturelli; Verónica Olavarría; Alexis Rojo; Juan Almeida; Violeta Díaz; Arnold Hoppe; Pablo Lavados Journal: Neuroradiology Date: 2018-05-22 Impact factor: 2.804
Authors: Tina M Burton; Marie Luby; Zurab Nadareishvili; Richard T Benson; John K Lynch; Lawrence L Latour; Amie W Hsia Journal: Neurology Date: 2017-06-28 Impact factor: 9.910